Patent US4304765A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4304765A Expired / Lapsed US ⏱️ 0.0 years remaining

Ocular insert housing steroid in two different therapeutic forms

Assignee: Alza Corp
•
Filing: 1980-10-14
•
Granted: 1981-12-08
•
Expires: 2000-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An ocular insert and an ocular composition are disclosed. The insert and the composition comprises a steroid in two different forms.

Inventors

  • 👤 John W. Shell
  • 👤 Robert M. Gale

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 20:14
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K9/0051

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 153 words
An ocular therapeutic insert sized, shaped and adapted for easy insertion and comfortable retention in an eye, the insert comprising a reservoir formed of non-toxic polymer, and a medication in the reservoir, said medication comprising a dosage amount of a pharmaceutically acceptable steroid selected from the group consisting of corticosteroids, glucocorticoid and antiinfammatory steroids, said steroid present in the insert in two different pharmaceutic and chemical forms selected from an alcohol and ester, alcohol and ether, ester and ether, acetal and ester and ester and ester, that are dispensed from the insert in a therapeutically effective amount to the tear fluid, with the amount of one form of the steroid dissolved in the fluid being independent of the amount of the different form of the same steroid dissolved in the fluid and their rate of penetration into eye tissue, which leads to a therapeutic and beneficial effect over a prolonged period of time.
Claim 2
Dependent Claim 153 words
An ocular therapeutic insert sized, shaped and adapted for easy insertion and comfortable retention in an eye, the insert comprising a reservoir formed of non-toxic polymer, and a medication in the reservoir, said medication comprising a dosage amount of a pharmaceutically acceptable steroid selected from the group consisting of corticosteroids, glucocorticoid and antiinfammatory steroids, said steroid present in the insert in two different pharmaceutic and chemical forms selected from an alcohol and ester, alcohol and ether, ester and ether, acetal and ester and ester and ester, that are dispensed from the insert in a therapeutically effective amount to the tear fluid, with the amount of one form of the steroid dissolved in the fluid being independent of the amount of the different form of the same steroid dissolved in the fluid and their rate of penetration into eye tissue, which leads to a therapeutic and beneficial effect over a prolonged period of time.
Claim 3
Dependent Claim 27 words
The ocular therapeutic insert for dispensing the medication comprising the same steroid in two different forms according to claim 1, wherein the reservoir is a polymeric matrix.
Claim 4
Dependent Claim 32 words
The ocular therapeutic insert for dispensing the medication comprising the same steroid in two different forms according to claim 1, wherein the reservoir is a container and the medication is present therein.
Claim 5
Dependent Claim 38 words
The ocular therapeutic insert for dispensing the medication comprising the same steroid in two different forms according to claim 1 wherein the reservoir comprises depots of the medication dispersed in and surrounded substantially individually by the polymeric material.
Claim 6
Dependent Claim 21 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert comprises betamethasone acetate and betamethasone valerate.
Claim 7
Dependent Claim 21 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert comprises dexamethasone and dexamethasone sodium phosphate.
Claim 8
Dependent Claim 20 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert comprises triamcinolone and triamcinolone acetonide.
Claim 9
Dependent Claim 38 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert is selected from the group consisting of hydrocortisone and hydrocortisone acetate, hydrocortisone sodium phosphate and hydrocortisone sodium succinate, and hydrocortisone and hydrocortisone cyclopentylpropionate.
Claim 10
Dependent Claim 37 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert is selected from the group consisting of prednisolone and prednisolone acetate, prednisolone sodium phosphate and prednisolone sodium succinate, methylprednisolone and methylprednisolone acetate.
Claim 11
Dependent Claim 20 words
The ocular therapeutic insert according to claim 1 wherein the same steroid in the insert in fluormetholone and fluormetholone acetate.
Claim 12
Dependent Claim 41 words
A method for treating ocular inflammation which method comprises positioning in the eye the ocular insert of claim 1, said insert releasing the same steroid in two different forms to the eye in a therapeutically effective amount for treating said inflammation.
Claim 13
Dependent Claim 49 words
A method for treating diseases of the eye, which method comprises placing in the eye the ocular insert of claim 1, and releasing a dosage unit amount of same steroid in two different forms to the eye in a therapeutically effective amount for treating the diseases of the eye.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-07 1985-06-08 1985-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-07 1989-06-08 1989-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-07 1993-06-08 1993-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag